Treatment of acute renal failure in multiple myeloma using different dialysis techniques: experience in one center.
PDF (Español (España))

How to Cite

1.
Hernández García E, Garnica Álvarez ML, Díaz Gómez L, Prados Garrido MD. Treatment of acute renal failure in multiple myeloma using different dialysis techniques: experience in one center. Rev. Colomb. Nefrol. [Internet]. 2022 Feb. 3 [cited 2022 May 18];9(1). Available from: https://revistanefrologia.org/index.php/rcn/article/view/558
https://doi.org/10.22265/acnef.9.1.558
PDF (Español (España))

References

Hutchison CA, Heyne N, Airia P, Schindler R, Zickler D, Cook M,et al. Immunoglobulinfree light chain levels and recovery from myeloma kidney on treatment with chemotherapyand high cut-off haemodialysis. Nephrol Dial Transplant. 2012;27(10):3823-28. doi: https://doi.org/10.1093/ndt/gfr773

Wennekers AB, Martín-Azara MP, Dourdil-Sahun V, Bergasa-Liberal B, Ruiz-Laiglesia JE,Vernet-Perna P,et al. Trece tratamientos de la insuciencia renal aguda secundaria a mie-loma múltiple con ltros de high cut off. Nefrología. 2016;36:418-26. doi: https://doi.org/10.1016/j.nefro.2016.03.011

Pendón-Ruiz MV, Álvarez-Lara MA, Ojeda-López R, Martín-Malo A, Carracedo J,Caballero-Villarraso J,et al. Ecacia de la hemodialtración con regeneración del ultra-filtrado en la reducción de cadenas ligeras en mieloma múltiple con insuciencia renal.Nefrología. 2013;33(6):788-96.

Álvarez-Lara MA, Martín-Malo A, Aljama-García P. Nuevas alternativas en el tratamiento del riñón del mieloma. Nefrología 2013; 33(4):443-7. http://scielo.isciii.es/pdf/nefrologia/v33n4/comentario_editorial.pdf

Sáez MI, Camarero V, Rosales A, Hijazi B, Izquierdo MJ, Labrador J,et al. Acute renal failurein patients with myeloma: Experience with extended high cut-off hemodialysis. Nefrología.2017;37(4):429-31. doi: https://doi.org/10.1016/j.nefro.2016.10.014

Sens F, Chaintreuil D, Jolivot A, Guebre-Egziabher F, Robinson P, Karlin L,et al. Effective-ness of IHD with Adsorptive PMMA Membrane in Myeloma Cast Nephropathy: A CohortStudy. Am J Nephrol. 2017;46:355-63. doi: https://doi.org/10.1159/000481461

Cazorla-López JM, García-Doncel A, Naranjo-Muñoz J, Villanego-Fernández F, Vigara-Sánchez LA, Ceballos-Guerrero M. Experiencia de hemodiálisis con dializador de me-diano poro en la nefropatía por cilindros del mieloma. Nefrología. 2020;40(3):367-9. doi:https://doi.org/10.1016/j.nefro.2019.09.008

Hutchison CA, Cockwell P, Moroz V, Bradwell AR, Fifer L, Gillmore JD,et al. High cu-toff versus high-ux haemodialysis for myeloma cast nephropathy in patients receivingbortezomib-based chemotherapy (EuLITE): a phase 2 randomised controlled trial. LancetHaematol. 2019;6(4) e217-28. doi: https://doi.org/10.1016/S2352-3026(19)30014-6

Bridoux F, Carron P, Pegourie B, Alamartine E, Augeul-Meunier K, Karras A,et al. Effect ofHigh-Cutoff Hemodialysis vs Conventional Hemodialysis on Hemodialysis IndependenceAmong Patients With Myeloma Cast Nephropathy: A Randomized Clinical Trial. JAMA.2017;318:2099-110. doi: https://doi.org/10.1001/jama.2017.17924

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Downloads

Download data is not yet available.